Overweight or obesity increases the risk of cardiovascular disease among older Australian adults, even in the absence of cardiometabolic risk factors: a Bayesian survival analysis from the Hunter Community Study
- 9 December 2022
- journal article
- research article
- Published by Springer Nature in International Journal of Obesity
- Vol. 47 (2) , 117-125
Abstract
Objective To estimate the risk of cardiovascular disease (CVD) in older adults with overweight or obesity without metabolic risk factors using a Bayesian survival analysis. Design Prospective cohort study with median follow-up of 9.7 years. Setting Newcastle, New South Wales, Australia. Participants A total of 2313 community-dwelling older men and women. Intervention/exposure Participants without known CVD and with a body mass index (BMI) ≥ 18.5 kg m2 were stratified by BMI and metabolic risk to create six BMI-metabolic health categories. Metabolic risk was defined according to the International Diabetes Federation criteria for metabolic syndrome. ‘Metabolically healthy’ was defined as absence of metabolic risk factors. Bayesian survival analysis, incorporating prior information from a previously published meta-analysis was used to assess the effect of BMI-metabolic health categories on time from recruitment to CVD. Main outcome Incident physician-diagnosed CVD, defined as fatal or nonfatal myocardial infarction, fatal or nonfatal stroke, angina, or coronary revascularisation procedure, was determined by linkage to hospital admissions records and Medicare Australia data. Secondary outcomes were cardiovascular mortality and all-cause mortality. Results From 2313 adults with complete metabolic health data over a median follow-up of 9.7 years, 283 incident CVD events, 58 CVD related deaths and 277 deaths from any cause occurred. In an adjusted Bayesian survival model of complete cases with informative prior and metabolically healthy normal weight as the reference group, the risk of CVD was increased in metabolically healthy overweight (HR = 1.52, 95% credible interval 0.96–2.36), and in metabolically healthy obesity (HR = 1.86, 95% credible interval 1.14–3.08). Imputation of missing metabolic health and confounding data did not change the results. Conclusion There was increased risk of CVD in older adults with overweight or obesity, even in the absence of any metabolic abnormality. This argues against the notion of ‘metabolically healthy’ overweight or obesity.Keywords
All Related Versions
This publication has 47 references indexed in Scilit:
- The intriguing metabolically healthy but obese phenotype: cardiovascular prognosis and role of fitnessEuropean Heart Journal, 2012
- "Toward a Clearer Definition of Confounding" Revisited With Directed Acyclic GraphsAmerican Journal of Epidemiology, 2012
- Effect of Different Obesity Phenotypes on Cardiovascular Events in Tehran Lipid and Glucose Study (TLGS)The American Journal of Cardiology, 2011
- Individual and Aggregate Years‐of‐life‐lost Associated With Overweight and ObesityObesity, 2010
- Impact of Body Mass Index and the Metabolic Syndrome on the Risk of Cardiovascular Disease and Death in Middle-Aged MenCirculation, 2010
- Cohort Profile: The Hunter Community StudyInternational Journal of Epidemiology, 2010
- The Obesity, Metabolic Syndrome, and Type 2 Diabetes Mellitus Pandemic: Part I. Increased Cardiovascular Disease Risk and the Importance of Atherogenic Dyslipidemia in Persons With the Metabolic Syndrome and Type 2 Diabetes MellitusJournal of the CardioMetabolic Syndrome, 2009
- Identification and Characterization of Metabolically Benign Obesity in HumansObstetrical & Gynecological Survey, 2009
- Comparison of Usefulness of Body Mass Index Versus Metabolic Risk Factors in Predicting 10-Year Risk of Cardiovascular Events in WomenThe American Journal of Cardiology, 2007
- Obesity in Adulthood and Its Consequences for Life Expectancy: A Life-Table AnalysisAnnals of Internal Medicine, 2003